Clearpoint Neuro stock target raised to $9 on growth momentum
On Wednesday, Stifel demonstrated confidence in Clearpoint Neuro Inc. (NASDAQ:CLPT) by increasing the stock\'s price target to $9.00, up from the previous $8.00, while reaffirming a Buy rating. This adjustment reflects the company\'s strong performance, which includes a 17% growth in top-line revenue and a significant reduction in cash burn for the year 2023. Clearpoint...